Treatment Satisfaction with Medicines in patients with multiple sclerosis and factors related in Sabzevar

Background: Multiple sclerosis, as the most common demyelinating disease of the central nervous system, requires continuous Adherence to Treatment due to its chronic nature.Therefore, according to the importance of Treatment Satisfaction with Medicines in Adherence to Treatment, the present study was conducted with the aim of determining the level of satisfaction with drug treatment and its associated factors in patients suffering from this disease in Sabzevar.Methods: This cross-sectional descriptive study was conducted on 44 MS patients who referred to treatment centers and Sabzevar MS Association from October 2022 to March 2023, using an easy and accessible non-probability sampling method.The data collection tool included demographic information questionnaire and Treatment Satisfaction with Medicines questionnaire (SATMED-Q).Data was analyzed by SPSS-23, using descriptive and inferential statistics such as one-way analysis of variance statistical and Pearson correlation coefficients.Results: The mean age of the patients was 38.9 years and most of the patients were female (70.5%).In this study, the mean score of Treatment Satisfaction with Medicines in patients was 59.5413.61.Among the dimensions of satisfaction, the highest mean score was related to the dimension of global satisfaction and the lowest mean was related to the dimension of side effects.Education, age and patient history showed significant relationships with patients satisfaction (P<0.05).Conclusion: Patient satisfaction is a crucial factor in disease control and improvement.In this study, satisfaction with pharmacological treatment among patients with multiple sclerosis, specifically regarding drug side effects, was not reported at a desirable level, highlighting the need for further investigation and follow-up by healthcare decision-makers.